Rikio Suzuki
- Co-authors
- Teru HideshimaPaul G. RichardsonFrancesca CottiniKenneth C. AndersonHiroto OhguchiGüllü GörgünNaoya MimuraDiana Cirstea
- Topics
- Multiple Myeloma Research and Treatments (15 papers)Protein Degradation and Inhibitors (7 papers)Cancer Mechanisms and Therapy (4 papers)
- Cited by
- HematologyMolecular BiologyOncology
- Journals
- Nature CommunicationsBloodPLoS ONE
- Partner nations
- JapanUnited StatesSingapore
In The Last Decade
Rikio Suzuki
25 papers receiving 661 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 495
- Hematology 253
- Oncology 172
- Pathology and Forensic Medicine 69
- Immunology 58
Countries citing papers authored by Rikio Suzuki
This map shows the geographic impact of Rikio Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rikio Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rikio Suzuki more than expected).
Fields of papers citing papers by Rikio Suzuki
This network shows the impact of papers produced by Rikio Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rikio Suzuki. The network helps show where Rikio Suzuki may publish in the future.
Co-authorship network of co-authors of Rikio Suzuki
This figure shows the co-authorship network connecting the top 25 collaborators of Rikio Suzuki. A scholar is included among the top collaborators of Rikio Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rikio Suzuki. Rikio Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 15 | |
| 6 | 2 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 5 | |
| 11 | 75 | |
| 12 | 87 | |
| 13 | 19 | |
| 14 | 24 | |
| 15 | 66 | |
| 16 | 47 | |
| 17 | 131 | |
| 18 | 8 | |
| 19 | 19 | |
| 20 | 15-Deoxyspergualin, an antiproliferative agent for human and mouse leukemia cells shows inhibitory effects on the synthetic pathway of polyamines. | 12 |
About Rikio Suzuki
Rikio Suzuki is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 30 papers that have together received 666 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (15 papers), Protein Degradation and Inhibitors (7 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Hematology (253 citations), Molecular Biology (495 citations) and Oncology (172 citations). Rikio Suzuki has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Teru Hideshima, Paul G. Richardson, Francesca Cottini, Kenneth C. Anderson, Hiroto Ohguchi, Güllü Görgün, Naoya Mimura, Diana Cirstea, Jana Jakubı́ková and Nikhil C. Munshi. Their work appears in journals such as Nature Communications, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.